AstraZeneca assumed with a Hold at Jefferies. Jefferies analyst Peter Welford assumed coverage of AstraZeneca with a Hold rating and $42 price target. The analyst is positive on the European large-cap Pharma space “as it enters a period of sustained earnings momentum.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.